Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1

Journal of Clinical Microbiology

Volumn 42, Issue 9, 2004, Pages 4365-4369

  Canobio, Sophie ^a,b   Guilbert, Cynthia M ^a,b   Troesch, Myriam ^a,b   Samson, Johanne ^a   Lemay, Mireille ^a,b   Pelletier, Veronique Anne ^a,b   Bernard Bonnin, Anne Claude ^a,b   Kozielski, Rafal ^a,c   Lapointe, Normand ^a,b   Martin, Steven R ^a,b   Soudeyns, Hugo ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOMODULATION; LIVER DISEASE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPECIES DIFFERENCE; SPECIES DIVERSITY; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INFANT; LIVER; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 4644319350     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.9.4365-4369.2004     Document Type: Article

References (35)

1. Babik, J. M., and M. Holodniy. 2003. Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients. J. Virol. 77:1940-1950.
2. Badizadegan, K., M. M. Jonas, M. J. Ott, S. F. Nelson, and A. R. Perez-Atayde. 1998. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 28:1416-1423.
3. Centers for Disease Control and Prevention. 1994. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morb. Mortal. Wkly. Rep. 43(RR-12):1-11.
4. Cerny, A., and F. V. Chisari. 1999. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30:595-601.
5. Cribier, B., D. Rey, C. Schmitt, J. M. Lang, A. Kirn, and F. Stoll-Keller. 1995. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 9:1131-1136.
6. Diepolder, H. M., R. Zachoval, R. M. Hoffmann, E. A. Wierenga, T. Santantonio, M. C. Jung, D. Eichenlaub, and G. R. Pape. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C infection. Lancet 346:1006-1007.
7. Farci, P., J. Bukh, and R. H. Purcell. 1997. The quasispecies of hepatitis C virus and the host immune response. Springer Semin. Immunopathol. 19:5-26.
8. Farci, P., A. Shimoda, A. Coiana, G. Diaz, G. Peddis, J. C. Melpolder, A. Strazzera, D. Y. Chien, S. J. Munoz, A. Balestrieri, R. H. Purcell, and H. J. Alter. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344.
9. Farci, P., R. Strazzera, H. J. Alter, S. Farci, D. Degioannis, A. Coiana, G. Peddis, F. Usai, G. Serra, L. Chessa, G. Diaz, A. Balestrieri, and R. H. Purcell. 2002. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc. Natl. Acad. Sci. USA 99:3081-3086.
10. Garcia-Monzon, C., P. Jara, M. Fernandez-Bermejo, L. Hierro, E. Frauca, C. Camarena, C. Diaz, A. De la Vega, J. Larrauri, C. Garcia-Iglesias, M. J. Borque, P. Sanz, L. Garcia-Buey, J. A. Moreno-Monteagudo, and R. Moreno-Otero. 1998. Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology 28:1696-1701.
11. Gaud, U., B. Langer, T. Petropoulou, H. C. Tomas, and P. Karayiannis. 2003. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects. J. Med. Viral. 69:350-356.
12. George, S. L., J. Gebhardt, D. Klinzman, M. B. Foster, K. D. Patrick, W. N. Schmidt, B. Alden, M. A. Pfaller, and J. T. Stapleton. 2002. Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests. J. Acquir. Immune Defic. Syndr. 31:154-162.
13. Hayashi, J., N. Furusyo, I. Ariyama, Y. Sawayama, Y. Etoh, and S. Kashiwagi. 2000. A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C virus viremia. J. Infect. Dis. 181:1523-1527.
14. John, M., J. Flexman, and M. A. French. 1998. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS 12:2289-2293.
15. Kumar, S., K. Tamura, I. B. Jakobsen, and M. Nei. 2001. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245.
16. Lechner, F., D. K. H. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191:1499-1512.
17. Mao, Q., S. C. Ray, O. Laeyendecker, J. R. Ticehurst, S. A. Strathdee, D. Vlahov, and D. L. Thomas. 2001. Human immunodeficiency virus seroconversion and evolution of hepatitis C virus quasispecies. J. Virol. 75:3259-3267.
18. Martell, M., J. I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, J. Guardia, and J. Gomez. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66:3225-3229.
19. Martin-Carbonero, L., V. Soriano, E. Valencia, J. Garcia-Samaniego, M. Lopez, and J. Gonzalez-Lahoz. 2001. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients. AIDS Res. Hum. Retrovir. 17:1467-1471.
20. Martin-Carbonero, L., M. Nunez, P. Rios, M. Perez-Olmeda, J. Gonzalez-Lahoz, and V. Soriano. 2002. Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution. AIDS 16:1423-1425.
21. Murphy, D., B. Willems, and G. Delage. 1994. Use of the 5′ noncoding region for genotyping hepatitis C virus. J. Infect. Dis. 169:473-475.
22. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
23. Papaevangelou, V., H. Pollack, G. Rochford, R. Kokka, Z. Hou, D. Chernoff, B. Hanna, K. Krasinsky, and W. Borkowsky. 1998. Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women. J. Infect. Dis. 178:1047-1052.
24. Polyak, S. J., S. McArdle, S. L. Liu, D. G. Sullivan, M. Chung, W. T. Hofgartner, R. L. Carithers, B. J. McMahon, J. I. Mullins, L. Corey, and D. R. Gretch. 1998. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J. Virol. 72:4288-4296.
25. Roque-Afonso, A. M., M. Robain, D. Simoneau, P. Rodriguez-Mathieu, M. Gigou, L. Meyer, and E. Dussaix. 2002. Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus. J. Infect. Dis. 185:728-733.
26. Sherman, K. E., C. Andreatta, J. O'Brien, A. Gutierrez, and R. Harris. 1996. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 23:688-694.
27. Spengler, U., and J. K. Rockstroh. 1998. Hepatitis C in the patient with human immunodeficiency virus infection. J. Hepatol. 29:1023-1030.
28. Tedaldi, E. M., R. K. Baker, A. C. Moorman, C. F. Alzola, J. Furhrer, R. E. McCabe, K. C. Wood, S. D. Holmberg, and HIV Outpatient Study Investigators. 2003. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 36:363-367.
29. Thomas, S. L., M. L. Newell, C. S. Peckham, A. E. Ades, and A. J. Hall. 1998. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int. J. Epidemiol. 27:108-117.
30. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 24:4876-4882.
31. Toyoda, H., Y. Fukuda, Y. Koyama, J. Takamatsu, H. Saito, and T. Hayakawa. 1997. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J. Hepatol. 26:975-982.
32. Vogt, M., T. Lang, G. Frosner, C. Klingler, A. F. Sendl, A. Zeller, B. Wiebecke, B. Langer, H. Meisner, and J. Hess. 1999. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N. Engl. J. Med. 341: 866-870.
33. Weiner, A. J., M. M. Thaler, K. Crawford, K. Ching, J. Kansopon, D. Y. Chien, J. E. Hall, F. Hu, and M. Houghton. 1993. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J. Virol. 67:4365-4368.
34. Weiner, A. J., H. M. Geysen, C. Christopherson, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, M. Brunetto, P. J. Barr, T. Miyamura, J. McHutchinson, and M. Houghton. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89:3468-3472.
35. Weintrub, P. S., G. Veereman-Wauters, M. J. Cowan, and M. M. Thaler. 1991. Hepatitis C virus infection in infants whose mothers took street drugs intravenously. J. Pediatr. 119:869-874.